MUSTANG BIO, INC. Land Subject to Ground Leases
MUSTANG BIO, INC. (MBIO) had Land Subject to Ground Leases of 27.04 thousand acre as of 2017-10-27, per its 10-K filed 2018-03-29.
Discontinued › Notes
us-gaap:LandSubjectToGroundLeases · last filed 2019-03-18
- 2017-10-27: Land Subject to Ground Leases 27.04K acre.
acre
| Period end | Land Subject to Ground Leases |
|---|---|
| 2017-10-27 | 27.04K acre 10-K · filed 2018-03-29 |
sqft
| Period end | Land Subject to Ground Leases |
|---|---|
| 2017-10-27 | 27.04K sqft 10-K · filed 2019-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B |